Lee D. Arnold - 01 Feb 2023 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)

Reporting relationship: Chief Scientific Officer
Issuer ticker: AEMD
Reported as of: 01 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Feb 2023, 15:14:07 UTC
Prior SEC filing: 02 Feb 2022
Source filing: View source filing
Reporting owner signature: /s/ Lee D. Arnold

Key filing fact

Lee D. Arnold filed Form 4 for AETHLON MEDICAL INC (AEMD) on 02 Feb 2023.

Key facts

This page summarizes Lee D. Arnold's Form 4 filing for AETHLON MEDICAL INC (AEMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Feb 2023, 15:14.

Change

Previous filing in this sequence was filed on 02 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AEMD transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +60,620
Change %
Price: $0.000000
Shares after: 60,620
Date: 01 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,620
Exercise price: $0.6900
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares subject to the stock option shall vest and become exercisable on February 1, 2024, and the remaining shares shall vest and become exercisable in 36 equal monthly installments thereafter.